Education
About Us
Working with TipRanks
Follow Us
Corcept Therapeutics (DE:HTD)
:HTD
Corcept Therapeutics (HTD) Ownership Overview
11.51% Insiders
16.90%
Mutual Funds
17.49% Other Institutional Investors
23.10% ETFs
31.01% Public Companies and Individual Investors
The ownership structure of Corcept Therapeutics (DE:HTD) stock is a mix of institutional, retail, and individual investors. Approximately 57.48% of the company’s stock is owned by Institutional Investors, 11.51% is owned by Insiders, and 31.01% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 18, 2025 | xxxxxxxxxxxxx | $225402 | |
May 22, 2025 | xxxxxxxxxxxxx | $172862 | |
May 20, 2025 | xxxxxxxxxxxxx | $2030389 | |
Nov 26, 2024 | xxxxxxxxxxxxx | $146626 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $285321 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $296743 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $951338 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $21623445 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,985,487 | Institution | 9.42% | 766,565,866 | |
| 9,156,081 | Institution | 8.63% | 702,894,026 | |
| 7,746,727 | Institution | 7.31% | 594,700,738 | |
| 5,310,196 | Insider | 5.01% | 407,653,127 | |
| 2,941,985 | Insider | 2.77% | 225,850,304 | |
| 2,346,235 | Insider | 2.21% | 180,115,768 | |
| 1,531,030 | Institution | 1.44% | 117,534,111 | |
| 1,258,761 | Insider | 1.19% | 96,632,564 | |
| 1,112,285 | Institution | 1.05% | 85,387,895 | |
| 1,035,933 | Institution | 0.98% | 79,526,505 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,746,727 | Institution | 7.31% | 594,700,738 | |
| 1,112,285 | Institution | 1.05% | 85,387,895 | |
| 933,725 | Institution | 0.88% | 71,680,201 | |
| 861,545 | Institution | 0.81% | 66,139,087 | |
| 794,072 | Institution | 0.75% | 60,959,319 | |
| 628,227 | Institution | 0.59% | 48,227,730 | |
| 483,346 | Institution | 0.46% | 37,105,506 | |
| 450,858 | Institution | 0.43% | 34,611,467 | |
| 357,578 | Institution | 0.34% | 27,450,548 | |
| 352,956 | Institution | 0.33% | 27,095,726 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Corcept Therapeutics (DE:HTD)?
According to the latest TipRanks data, approximately 17.49% of the company's stock is held by institutional investors, 11.51% is held by insiders, and 31.01% is held by retail investors.
What percentage of Corcept Therapeutics (DE:HTD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 17.49% of Corcept Therapeutics (DE:HTD) stock is held by institutional investors.
What percentage of Corcept Therapeutics (DE:HTD) stock is held by retail investors?
According to the latest TipRanks data, approximately 31.01% of Corcept Therapeutics (DE:HTD) stock is held by retail investors.
Who owns the most shares of Corcept Therapeutics (DE:HTD)?
iShares owns the most shares of Corcept Therapeutics (DE:HTD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.